Clinical Trial Update: Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Meniscus Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial investigating ketorolac as an adjuvant for postoperative pain control after arthroscopic meniscus surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meniscal Tear
• Postoperative Pain

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Meniscus Tear, Tibial, Pain, Postoperative | Phase 3 | Status: COMPLETED | Results posted: 2021-12-01